BridgeMD
New treatment option for PTSD (Childbirth-Related)
Official title Preventing Childbirth-Related PTSD With Expressive Writing
ClinicalTrials.gov ID: NCT05662423
What this study is testing
- What it's testing
- The goal of this clinical trial is to test a brief psychological intervention given to individuals in the first days following childbirth who have experienced a potentially stressful childbirth. The treatment is aimed at preventing post-traumatic stress disorder following childbirth and promoting maternal-infant bonding.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50, women only. Healthy volunteers may be eligible.
You may be able to join if
- Women who recently delivered at Massachusetts General Hospital (MGH).
- Women who are at risk for developing CB-PTSD based on their scoring of \>16 on the Peritraumatic Distress Inventory (PDI).
You likely can't join if
- Age \ 50.
- Stillbirth.
- Down's Syndrome, other serious genetic disorder in the newborn, or serious birth defect (e.g., microcephaly, spina bifida).
- Admission to the neonatal intensive care unit (NICU) for more than 1 week or infant that is not medically healthy.
- Current diagnosable DSM-5 psychotic or bipolar disorder, or current substance abuse disorder.
- Active suicidality (assessed case by case).
See the full eligibility criteria
- Women who recently delivered at Massachusetts General Hospital (MGH).
- Women who are at risk for developing CB-PTSD based on their scoring of \>16 on the Peritraumatic Distress Inventory (PDI).
- Age \ 50.
- Stillbirth.
- Down's Syndrome, other serious genetic disorder in the newborn, or serious birth defect (e.g., microcephaly, spina bifida).
- Admission to the neonatal intensive care unit (NICU) for more than 1 week or infant that is not medically healthy.
- Current diagnosable DSM-5 psychotic or bipolar disorder, or current substance abuse disorder.
- Active suicidality (assessed case by case).
- Present substance abuse as indicated in medical records.
- Severe maternal morbidity (assessed case by case).
- General anesthesia.
- Inability to understand the study procedures, risks, and side effects, or to otherwise give informed consent for participation due to neurological or other reasons.
- Inability to understand English.
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 50 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.